Effects of oral administration of insulin-like growth factor-I on circulating concentration of insulin-like growth factor-I and growth of internal organs in weanling mice

被引:7
|
作者
Kim, WK
Ryu, YH
Seo, DS
Lee, CY
Ko, Y [1 ]
机构
[1] Korea Univ, Coll Life & Environm Sci, Div Life Sci & Genet Engn, Seoul 136701, South Korea
[2] Jinju Natl Univ, Reg Anim Ind Res Ctr, Jinju, South Korea
来源
BIOLOGY OF THE NEONATE | 2006年 / 89卷 / 03期
关键词
insulin-like growth factor-1; oral administration; growth; organ; mouse;
D O I
10.1159/000089796
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Insulin-like growth factor (IGF)-I is a polypeptide that mediates the growth-promoting action of growth hormone in postnatal animals. The present study was conducted to examine whether orally administered IGF-I would be absorbed into the general circulation and also whether ingested IGF-I would enhance the growth of whole body as well as internal organs, and tissues in 3-week-old ICR-strain female weanling mice. In experiment (Exp) 1, a total of 70 mice received IGF-I orally at 1 mu g.g(-1) in 0.2-ml PBS or the vehicle alone. Concentrations of IGF-I and glucose in heart blood were measured after killing 5 animals in each group every fourth hour during a 24-hour period. In Exp 2, a total of 40 mice received oral IGF-I administration at 1 mu g.g(-1) or vehicle every third day beginning from day 0 for a 13-day period. Half the animals were killed at day 7 and the other half at day 13. Weights of whole body and organs/tissues (small intestine, liver, thigh muscle, and brain) were measured every day and at slaughter, respectively. In Exp 1, following the oral IGF-I administration, serum IGF-I concentration increased at hour 4 (p<0.01) and returned to the hour 0 level by hour 8, whereas glucose concentration was lowest at hour 4 and returned to the hour 0 level by hour 16. In the PBS-fed group, neither IGF-I nor glucose concentration changed during the 24-hour period. In Exp 2, weight of small intestine increased (p<0.05) in response to the oral IGF-I, whereas weights of liver and thigh muscle of the IGF-I-fed group were greater (p<0.01) and tended to be greater (p=0.06), respectively, than those of the PBS-fed only at day 13. However, brain weight and serum concentrations of IGF-I and IGF-II were not affected by oral IGF-I administration. Results suggest that although orally administered IGF-I mainly acts at the intestine, a portion of ingested IGF-I is absorbed into the general circulation to enhance the growth of selective organs/tissues in weanling mice. Copyright (C) 2006 S. Karger AG, Basel.
引用
下载
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [21] INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ARE PRESENT IN FETAL NEURON CELL-CULTURE
    SCHECHTER, R
    WHITMIRE, J
    HARLOW, R
    JACKSON, K
    GAVIN, JR
    CLINICAL RESEARCH, 1991, 39 (04): : A857 - A857
  • [22] Effects of intravenous insulin-like growth factor-I and insulin administration on insulin-like growth factor-binding proteins in the ovine fetus
    Shen, WH
    Yang, X
    Boyle, DW
    Lee, WH
    Liechty, EA
    JOURNAL OF ENDOCRINOLOGY, 2001, 171 (01) : 143 - 151
  • [23] INSULIN-LIKE GROWTH FACTOR-I INCREASES INSULIN SENSITIVITY
    SAAD, MF
    MAALOUT, NB
    KADES, WW
    WASSILY, VM
    VITOLINS, MZ
    SEAGLE, HM
    MEEHAN, WP
    DIABETOLOGIA, 1993, 36 : A68 - A68
  • [24] SYNTHESIS OF AN INSULIN-LIKE GROWTH FACTOR-I HYBRID INSULIN
    GEIGER, R
    LANGNER, D
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1981, 362 (06): : 799 - 807
  • [25] INSULIN-LIKE GROWTH FACTOR-I STIMULATION OF LYMPHOPOIESIS
    CLARK, R
    STRASSER, J
    MCCABE, S
    ROBBINS, K
    JARDIEU, P
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02): : 540 - 548
  • [26] Bioactive Insulin-Like Growth Factor-I in Obesity
    Frystyk, J.
    Brick, D. J.
    Gerweck, A. V.
    Utz, A. L.
    Miller, K. K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (08): : 3093 - 3097
  • [27] Insulin-like growth factor-I and cancer risk
    Ibrahim, YH
    Yee, D
    GROWTH HORMONE & IGF RESEARCH, 2004, 14 (04) : 261 - 269
  • [28] INVIVO EFFECTS OF INSULIN-LIKE GROWTH FACTOR-I IN RATS
    HIZUKA, N
    TAKANO, K
    ASAKAWA, K
    MIYAKAWA, M
    TANAKA, I
    HORIKAWA, R
    HASEGAWA, S
    MIKASA, Y
    SAITO, S
    SHIBASAKI, T
    SHIZUME, K
    ENDOCRINOLOGIA JAPONICA, 1987, 34 : 115 - 121
  • [29] THERAPEUTIC POTENTIAL OF INSULIN-LIKE GROWTH FACTOR-I
    FROESCH, ER
    GULER, HP
    SCHMID, C
    BINZ, K
    ZAPF, J
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1990, 1 (05): : 254 - 260
  • [30] INSULIN-LIKE GROWTH FACTOR-I IN PATIENTS WITH HYPOGLYCEMIA
    LABIB, M
    TEALE, D
    MARKS, V
    ANNALS OF CLINICAL BIOCHEMISTRY, 1990, 27 : 107 - 109